Pharmaceutical and Life Sciences Law Archivos - Faus Moliner https://faus-moliner.com/en/category/publications/pharmaceutical-and-life-sciences-law-2/ Otro sitio realizado con WordPress Mon, 06 Oct 2025 15:42:38 +0000 en-US hourly 1 https://wordpress.org/?v=6.8.3 El interés público prevalece: las resoluciones de precio y reembolso de medicamentos son confidenciales https://faus-moliner.com/en/el-interes-publico-prevalece-las-resoluciones-de-precio-y-reembolso-de-medicamentos-son-confidenciales-2/ Tue, 02 Sep 2025 13:33:06 +0000 https://faus-moliner.com/el-interes-publico-prevalece-las-resoluciones-de-precio-y-reembolso-de-medicamentos-son-confidenciales-2/ This article analyzes the latest rulings by the Contentious-Administrative Chamber of the National High Court regarding the confidentiality of pricing & reimbursement decisions for two medicinal products.  Specifically the reasoning judgments to conclude that these documents must remain confidential and cannot be accessed through Law 19/2013 of December 9, on Transparency, Access to Public Information,...

Read More

La entrada El interés público prevalece: las resoluciones de precio y reembolso de medicamentos son confidenciales aparece primero en Faus Moliner.

]]> This article analyzes the latest rulings by the Contentious-Administrative Chamber of the National High Court regarding the confidentiality of pricing & reimbursement decisions for two medicinal products.  Specifically the reasoning judgments to conclude that these documents must remain confidential and cannot be accessed through Law 19/2013 of December 9, on Transparency, Access to Public Information, and Good Governance are analyzed.

La entrada El interés público prevalece: las resoluciones de precio y reembolso de medicamentos son confidenciales aparece primero en Faus Moliner.

]]> Retos y oportunidades del Anteproyecto de Ley de Medicamentos y Productos Sanitarios https://faus-moliner.com/en/retos-y-oportunidades-del-anteproyecto-de-ley-de-medicamentos-y-productos-sanitarios-2/ Tue, 02 Sep 2025 13:14:09 +0000 https://faus-moliner.com/retos-y-oportunidades-del-anteproyecto-de-ley-de-medicamentos-y-productos-sanitarios-2/ This article examines the main developments introduced by the Draft Bill on Medicinal Products and Medical Devices regarding the regulation of medicinal products in Spain. Based on a detailed analysis of its content, the most relevant advances and critical issues are indentified, and proposals for improvement are put forward.

La entrada Retos y oportunidades del Anteproyecto de Ley de Medicamentos y Productos Sanitarios aparece primero en Faus Moliner.

]]> This article examines the main developments introduced by the Draft Bill on Medicinal Products and Medical Devices regarding the regulation of medicinal products in Spain. Based on a detailed analysis of its content, the most relevant advances and critical issues are indentified, and proposals for improvement are put forward.

La entrada Retos y oportunidades del Anteproyecto de Ley de Medicamentos y Productos Sanitarios aparece primero en Faus Moliner.

]]> Global Legal Insights to: Pricing & Reimbursement 2025 https://faus-moliner.com/en/global-legal-insights-to-pricing-reimbursement-2025/ Mon, 01 Sep 2025 13:13:03 +0000 https://faus-moliner.com/global-legal-insights-to-pricing-reimbursement-2025/ The eighth edition of Pricing & Reimbursement has been recently published and as in previous years Jordi Faus, with the collaboration of Lluís Alcover and Joan Carles Bailach, has been in charge of the chapter dedicated to pricing and reimbursement in Spain. GLI Pricing & Reimbursement 2025 includes the following sections for each of the...

Read More

La entrada Global Legal Insights to: Pricing & Reimbursement 2025 aparece primero en Faus Moliner.

]]> The eighth edition of Pricing & Reimbursement has been recently published and as in previous years Jordi Faus, with the collaboration of Lluís Alcover and Joan Carles Bailach, has been in charge of the chapter dedicated to pricing and reimbursement in Spain.

GLI Pricing & Reimbursement 2025 includes the following sections for each of the 18 analyzed countries:

  • Market overview;
  • Financing and pricing of medicinal products;
  • Policy issues that affect pricing and reimbursement; and
  • Emerging trends

La entrada Global Legal Insights to: Pricing & Reimbursement 2025 aparece primero en Faus Moliner.

]]> Faus Moliner participates in «Chambers Global Practices Guides – Product Liability & Safety 2025» https://faus-moliner.com/en/faus-moliner-participa-en-chambers-global-practices-guides-product-liability-safety-2025/ Wed, 16 Jul 2025 12:49:00 +0000 https://faus-moliner.com/?p=38796 The “Chambers Global Practices Guides” publication is a practical reference that provides easily accessible information for browsing the legal system when conducting business in different jurisdictions. Leading lawyers in the sector explain local laws and practices in key transaction stages and for crucial aspects of doing business.

La entrada Faus Moliner participates in «Chambers Global Practices Guides – Product Liability & Safety 2025» aparece primero en Faus Moliner.

]]> The “Chambers Global Practices Guides” publication is a practical reference that provides easily accessible information for browsing the legal system when conducting business in different jurisdictions. Leading lawyers in the sector explain local laws and practices in key transaction stages and for crucial aspects of doing business.

La entrada Faus Moliner participates in «Chambers Global Practices Guides – Product Liability & Safety 2025» aparece primero en Faus Moliner.

]]> Retos y oportunidades del Anteproyecto de Ley de medicamentos y productos sanitarios https://faus-moliner.com/en/retos-y-oportunidades-del-anteproyecto-de-ley-de-medicamentos-y-productos-sanitarios/ Fri, 11 Jul 2025 14:28:00 +0000 https://faus-moliner.com/?p=38660 This article examines the main developments introduced by the Draft Bill on Medicinal productsand Medical Devices regarding the regulation of medicinal products in Spain. Based on a detailedanalysis of its content, the most relevant advances and critical issues are identified, and proposals forimprovement are put forward.

La entrada Retos y oportunidades del Anteproyecto de Ley de medicamentos y productos sanitarios aparece primero en Faus Moliner.

]]> This article examines the main developments introduced by the Draft Bill on Medicinal products
and Medical Devices regarding the regulation of medicinal products in Spain. Based on a detailed
analysis of its content, the most relevant advances and critical issues are identified, and proposals for
improvement are put forward.

La entrada Retos y oportunidades del Anteproyecto de Ley de medicamentos y productos sanitarios aparece primero en Faus Moliner.

]]> El interés público prevalece: las resoluciones de precio y reembolso de medicamentos son confidenciales https://faus-moliner.com/en/el-interes-publico-prevalece-las-resoluciones-de-precio-y-reembolso-de-medicamentos-son-confidenciales/ Tue, 08 Jul 2025 14:00:47 +0000 https://faus-moliner.com/el-interes-publico-prevalece-las-resoluciones-de-precio-y-reembolso-de-medicamentos-son-confidenciales/ This article analyzes the latest rulings by the Contentious-Administrative Chamber of the National High Court regarding the confidentiality of pricing and reimbursement decisions for two medicinal products. Specifically, the reasoning of the judgments to conclude that these documents must remain confidential and cannot be accessed through Law 19/2013, of December 9, on Transparency, Access to...

Read More

La entrada El interés público prevalece: las resoluciones de precio y reembolso de medicamentos son confidenciales aparece primero en Faus Moliner.

]]> This article analyzes the latest rulings by the Contentious-Administrative Chamber of the National High Court regarding the confidentiality of pricing and reimbursement decisions for two medicinal products. Specifically, the reasoning of the judgments to conclude that these documents must remain confidential and cannot be accessed through Law 19/2013, of December 9, on Transparency, Access to Public Information, and Good Governance are analyzed.

La entrada El interés público prevalece: las resoluciones de precio y reembolso de medicamentos son confidenciales aparece primero en Faus Moliner.

]]> Faus Moliner participates in «International Comparative Legal Guide to Product Liability 2025» https://faus-moliner.com/en/faus-moliner-participa-en-international-comparative-legal-guide-to-product-liability-2025/ Fri, 13 Jun 2025 13:18:00 +0000 https://faus-moliner.com/faus-moliner-participa-en-international-comparative-legal-guide-to-product-liability-2025/ The 2025 edition of the magazine International Comparative Legal Guide to Product Liability is now available. The Guide offers a practical insight into product liability issues across the world, and includes general articles on novelties in the field of product liability and country specific Q&A chapters. Xavier Moliner and Juan Martínez were in charge of...

Read More

La entrada Faus Moliner participates in «International Comparative Legal Guide to Product Liability 2025» aparece primero en Faus Moliner.

]]> The 2025 edition of the magazine International Comparative Legal Guide to Product Liability is now available. The Guide offers a practical insight into product liability issues across the world, and includes general articles on novelties in the field of product liability and country specific Q&A chapters. Xavier Moliner and Juan Martínez were in charge of chapter 16 dedicated to the product liability regime in Spain.

La entrada Faus Moliner participates in «International Comparative Legal Guide to Product Liability 2025» aparece primero en Faus Moliner.

]]> Faus Moliner participates in «Chambers Global Practices Guides – Life Sciences 2025» https://faus-moliner.com/en/faus-moliner-participa-en-chambers-global-practices-guides-life-sciences-2025/ Tue, 13 May 2025 13:11:35 +0000 https://faus-moliner.com/faus-moliner-participa-en-chambers-global-practices-guides-life-sciences-2025/ The new Life Sciences 2025 guide features close to 20 jurisdictions. The guide provides the latest legal information on the regulatory framework for life sciences; clinical trials; the marketing, manufacturing and distribution of pharmaceuticals and medical devices; their import, export and pricing; and regulatory reliance and fast-track registration.

La entrada Faus Moliner participates in «Chambers Global Practices Guides – Life Sciences 2025» aparece primero en Faus Moliner.

]]> The new Life Sciences 2025 guide features close to 20 jurisdictions. The guide provides the latest legal information on the regulatory framework for life sciences; clinical trials; the marketing, manufacturing and distribution of pharmaceuticals and medical devices; their import, export and pricing; and regulatory reliance and fast-track registration.

La entrada Faus Moliner participates in «Chambers Global Practices Guides – Life Sciences 2025» aparece primero en Faus Moliner.

]]> El medicamento en los tribunales 2024 https://faus-moliner.com/en/el-medicamento-en-los-tribunales-2024/ Thu, 08 May 2025 08:22:19 +0000 https://faus-moliner.com/el-medicamento-en-los-tribunales-2024/ La entrada El medicamento en los tribunales 2024 aparece primero en Faus Moliner.

]]> La entrada El medicamento en los tribunales 2024 aparece primero en Faus Moliner.

]]> Faus Moliner participates en “International Comparative Legal Guide – Drug & Medical Device Litigation 2025”   https://faus-moliner.com/en/faus-moliner-participa-en-international-comparative-legal-guide-drug-medical-device-litigation-2025/ Tue, 15 Apr 2025 14:11:00 +0000 https://faus-moliner.com/faus-moliner-participa-en-international-comparative-legal-guide-drug-medical-device-litigation-2025/ The 2025 edition of the International International Comparative Legal Guide to Drug & Medical Device Litigation magazine is now available. The Guide offers a practical insight into drug and medical devices litigation issues across the world. Xavier Moliner and Juan Martinez were in charge of chapter 14 dedicated to drug and medical device litigation.

La entrada Faus Moliner participates en “International Comparative Legal Guide – Drug & Medical Device Litigation 2025”   aparece primero en Faus Moliner.

]]> The 2025 edition of the International International Comparative Legal Guide to Drug & Medical Device Litigation magazine is now available. The Guide offers a practical insight into drug and medical devices litigation issues across the world.

Xavier Moliner and Juan Martinez were in charge of chapter 14 dedicated to drug and medical device litigation.

La entrada Faus Moliner participates en “International Comparative Legal Guide – Drug & Medical Device Litigation 2025”   aparece primero en Faus Moliner.

]]>